(TSX:TSK),(OTC US:TSKFF),(Other OTC:TSKFF),(TSX:TSK-WT), TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Talisker Resources Ltd. (“Talisker” or the “Company“) (TSX: TSK, OTCQX: TSKFF) announces that further to the Company's news release of December 17, 2025, the Company has successfully reduced staffing levels at the Bralorne Mine in accordance with its Emergency Response Plan in response to restricted […]

(NasdaqGM:AVDL), – Data expected in Q2 2026 – DUBLIN, Dec. 18, 2025 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced the completion of patient enrollment in REVITALYZ, a Phase 3 trial evaluating LUMRYZTM (sodium oxybate) extended-release oral suspension as a potential treatment for idiopathic

(NASDAQ:NDAQ), Largest Exchange Transfer in History & Biggest IPO of the Year Highest Capital Raised Since 2021 – $46.65 Billion Raised NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) announced today that in 2025 it raised a total of $46.65 billion from new listings, marking the strongest year for capital raise since

(NasdaqGM:GANX), Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid (CSF), a prespecified endpoint The reduction in GluSph in CSF, a first-ever observation following the administration of a GCase modulator to PD patients, suggests increased GCase activity in the brain, which is expected to impact the progression of Parkinson's

(NASDAQ:LFCR),(NasdaqGM:NBI), CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has been notified by Nasdaq that the company's stock is expected to be added to the Nasdaq Biotech Index (NASDAQ: NBI) as part of the annual reconstitution

Toronto, Ontario, Dec. 18, 2025 (GLOBE NEWSWIRE) — King's Hawaiian, known for its irresistibly soft, fluffy, and signature sweet rolls, is bringing a taste of paradise to Toronto this holiday season with a limited-time pop-up at The Well. From December 18 to 21, 2025, King's Hawaiian will host a Holiday Happy Hour from 3 to

(NasdaqGM:RAPP), BOSTON and SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological and psychiatric disorders, today announced that management plans to present at the 44th Annual J.P. Morgan

(PinkSheets:BSEM),(Pinksheets:BSEM), Status Quo designation preserves DFU/VLU reimbursement eligibility for 2026, ensuring continued patient access to BioStem technology Coverage for the majority of BioStem's non-acute revenue, treatment for pressure ulcers, also remains unaffected by CMS LCD updates POMPANO BEACH, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused

Washington, D.C., Dec. 18, 2025 (GLOBE NEWSWIRE) — A video presentation from Wall Street Journal bestselling author and technology analyst James Altucher is now available, offering viewers a detailed examination of Elon Musk's Starlink network and why growing industry attention has centered on the possibility of a public offering in 2026. The presentation, delivered entirely

(TSX-V:APGO),(OTC US:APGOD),(OTCQB:APGOD),(Frankfurt:6ZF.F),(OTC US:APGOF),(Other OTC:APGOF), VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Apollo Silver Corp. (“Apollo Silver” or the “Company“) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF) is pleased to announce that, through its wholly owned subsidiary, Stronghold Silver USA Corp., the Company has completed all payments required under the Option to Purchase Agreement dated December 21, 2020,